67683-61-8Relevant academic research and scientific papers
Method of treating noradrenaline dysfunction or for dopamine-β-hydroxylase inhibition
-
, (2008/06/13)
A method of treating mammalian noradrenaline malfunctions or dysfunction or effecting dopamine-β-hydroxylase inhibition comprises administering an effective dose of an acid derivative of the formula (I), STR1 wherein R is C2-4 alkenyl, C3-8 cycloalkyl, benzyl or C1-6 alkyl which has a C1-4 alkoxy or a hydroxy substituent, or C2-6 alkyl with a carboxy and/or amino substituent, or C5 - or C6 -unsubtituted alkyl.
2-Amino-cyclopent-1-ene-1-dithiocarboxylic acids
-
, (2008/06/13)
2-Amino-cyclopent-1-ene-1-dithiocarboxylic acid derivatives of the formula, STR1 wherein R is C2-4 alkenyl, or C1-6 alkyl group having optionally a C1-4 alkoxy, hydroxy, carboxy and/or amino substituent, with the proviso that if R is an unsubstituted alkyl group, this group contains at least 5 carbon atoms, are prepared by reacting 2-amino-cyclopent-1-ene-1-dithiocarboxylic acid or a salt thereof with an amine of the formula, wherein R is as defined above. The new compounds of the invention exert dopamine-β-hydroxylase inhibiting effects.
